2020 Annual Meeting | P1 - Poster Session 1

Date Saturday 04/25/20

Time 12:00 PM - 01:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Sleep, Aging, Dementia, and Behavioral Neurology, Autoimmune Neurology, Cerebrovascular Disease and Interventional Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology

CME Available 0.00 credit

Event Timeline
12:00 PM - 01:00 PM	Abstract	9-001 - Reappraisal of Old Assumptions: Patient-Reported Memory (But Not Objective Memory) is Linked to Hippocampal Volume in Early Multiple Sclerosis Lisa Glukhovsky, PhD
12:00 PM - 01:00 PM	Abstract	9-002 - T2 Lesion Burden Modifies The Association Between Serum Neurofilament And Clinical Outcomes In MS PATHS (Partners Advancing Technology And Health Solutions) Kathryn Fitzgerald, PhD
12:00 PM - 01:00 PM	Abstract	9-003 - Decreased Activation of Deep Grey Matter Structures in Patients with Multiple Sclerosis Without Cognitive Deficits Martin Berghoff, MD, FAAN
12:00 PM - 01:00 PM	Abstract	9-004 - Multi-center Characterization of Brain Atrophy and Lesion Accrual Rates in Pediatric Multiple Sclerosis Assessed on Clinical-routine T2-FLAIR MRI Using the NeuroSTREAM and SCLV Techniques Michael G. Dwyer III, MD, PhD
12:00 PM - 01:00 PM	Abstract	9-005 - Determining the Impact of Ocrelizumab on Chronic Active Lesions in Multiple Sclerosis Utilizing Quantitative Susceptibility Mapping Neha Safi, MD
12:00 PM - 01:00 PM	Abstract	9-006 - 3T vs. 7T MRI Scan Protocols to Assess Deep Grey Matter Lesions and Atrophy in Relapsing-remitting Multiple Sclerosis Youmna Jalkh
12:00 PM - 01:00 PM	Abstract	9-007 - Magnetic Resonance Imaging (MRI) Metrics in Routine Clinical Practice: Proof of Concept in MS PATHS (Multiple Sclerosis Partners Advancing Technology for Health Solutions) Elizabeth Fisher
12:00 PM - 01:00 PM	Abstract	9-008 - Clinical Disability Worsening Correlates Preferentially with Atrophy of Thalamic Subregions in Patients with Multiple Sclerosis Kedar Mahajan, MD, PhD
12:00 PM - 01:00 PM	Abstract	9-009 - Medulla Oblongata Atrophy in Early Stage Multiple Sclerosis Laura Sander, MD
12:00 PM - 01:00 PM	Abstract	9-010 - Hippocampal Regional Vulnerability to Damage Differs Between MS and Neuromyelitis Optica Laura Cacciaguerra, MD, PhD
12:00 PM - 01:00 PM	Abstract	9-011 - Achieving Human Level Performance for Automatic Lesion Segmentation in Multiple Sclerosis with Deep Learning
12:00 PM - 01:00 PM	Abstract	9-012 - Foveal Shape Differs Between Neuromyelitis Optica and Multiple Sclerosis Patients Seyedamirhosein Motamedi, PhD
12:00 PM - 01:00 PM	Abstract	9-013 - MRI-Based Clustering of Multiple Sclerosis Patients in the Perspective of Personalized Medicine
12:00 PM - 01:00 PM	Abstract	9-014 - White Matter Tractometry Correlates with Fatigue Severity in Young Adults with Multiple Sclerosis Ann-Marie Beaudoin
12:00 PM - 01:00 PM	Abstract	9-015 - Thalamus Atrophy is Not a Predictor of Cognitive Performance in Multiple Sclerosis Patients with Previous Optic Neuritis Ana Margarida Novo, MD
12:00 PM - 01:00 PM	Abstract	9-016 - MRI Features of Progressive Multifocal Leukoencephalopathy: Cortical Susceptibility Changes Moein Amin, MD
12:00 PM - 01:00 PM	Abstract	9-017 - The Association Between MRI Brain Volumes and Computerized Cognitive Scores of People with Multiple Sclerosis Daniel Golan, MD
12:00 PM - 01:00 PM	Abstract	9-018 - Cortical and Deep Gray Matter Perfusion is Associated with Physical and Cognitive Performance in Multiple Sclerosis Patients Dejan Jakimovski, MD, PhD
12:00 PM - 01:00 PM	Abstract	9-019 - Quantitative MRI in Multiple Sclerosis Patients with Hypertension Justin Abbatemarco, MD
12:00 PM - 01:00 PM	Abstract	9-020 - Measurement of White Matter Atrophy in Multiple Sclerosis Using Diffusion Weighted Imaging Loredana Storelli
12:00 PM - 01:00 PM	Abstract	9-021 - Differences in Functional Connectivity Assessed by Graph Measures in Primary and Secondary Progressive Multiple Sclerosis Patients
12:00 PM - 01:00 PM	Abstract	9-022 - Effects of Fingolimod and Natalizumab on Brain T1/T2-Weighted and Magnetization Transfer Ratios: A 2-Year Study Maria A. Rocca
12:00 PM - 01:00 PM	Abstract	15-001 - Mercury-induced Neurotoxicity and Neuroinflammation: A Role for Heavy Metal Intoxication in the Pathogenesis of Autoimmune Diseases of the Nervous System Ekta G. Shah, DO, MS
12:00 PM - 01:00 PM	Abstract	15-002 - Case Report: The Use of Tocilizumab in Down Syndrome Disintegrative Disorder Alexander Sandweiss, MD, PhD
12:00 PM - 01:00 PM	Abstract	15-003 - Effects of EphB4-HAS on Human Microglial Cell Line Nizar Souayah, MD, FAAN
12:00 PM - 01:00 PM	Abstract	15-004 - Stiff-Person Spectrum Disorders Can Be Highly Underdiagnosed in Russia: a Retrospective Analysis Yury Seliverstov, MD, PhD
12:00 PM - 01:00 PM	Abstract	15-005 - Susac Syndrome Revisited: A Novel Presentation Zoya Zaeem, MD
12:00 PM - 01:00 PM	Abstract	15-006 - Two Cases of Susac Syndrome Mimicking Multiple Sclerosis. Shitiz K. Sriwastava, MBBS
12:00 PM - 01:00 PM	Abstract	15-007 - Hypothalamic Relapse in Neuromyelitis Optica Mary Clare McKenna, MB BCh BAO PhD
12:00 PM - 01:00 PM	Abstract	15-008 - Neuromyelitis Optica Spectrum Disorder Presenting as Symmetric, Bilateral Cranial Nerve Palsies Alise K. Carlson, MD
12:00 PM - 01:00 PM	Abstract	15-009 - Pruritus as initial symptom of Neuromyelitis Optica Spectrum Disorder. A Peruvian case report
12:00 PM - 01:00 PM	Abstract	15-010 - Paraneoplastic Parkinsonism-Dysautonomia Due To Anti-Hu Antibodies Vito A. Ricigliano
12:00 PM - 01:00 PM	Abstract	15-011 - Fulminant Transverse Myelitis and Reversible Cerebral Vasculopathy in an Aquaporin-4-Antibody Positive Patient With Active Systemic Lupus Erythematosus David Gritsch, MD, PhD
12:00 PM - 01:00 PM	Abstract	3-001 - Blood-Brain Barrier Opening with Focused Ultrasound in Parkinson´s Disease Dementia: A Safety and Feasibility Study Carmen Gasca-Salas, MD
12:00 PM - 01:00 PM	Abstract	3-002 - Outcomes of a Prospective, Multicenter, International Registry of Deep Brain Stimulation for Parkinson's Disease Guenther Deuschl, MD, FAAN
12:00 PM - 01:00 PM	Abstract	3-003 - Patient-Selected Goal Achievement and Satisfaction After Bilateral STN-DBS in Parkinson's Disease Seon Kyung Nam, MD
12:00 PM - 01:00 PM	Abstract	3-004 - Real-World Clinical Outcomes Using a Novel Directional Lead from a DBS Registry for Parkinson's Disease Guenther Deuschl, MD, FAAN
12:00 PM - 01:00 PM	Abstract	3-005 - Neuro-Anatomical Volumetric Changes in Deep Brain Stimulation of Parkinson’s Disease Patients Drew S. Kern, MD, FAAN
12:00 PM - 01:00 PM	Abstract	3-006 - Clinical Outcomes from Directional Deep Brain Stimulation in Parkinson's Disease Patients: A Retrospective Analysis Alina Shub, PA
12:00 PM - 01:00 PM	Abstract	3-007 - Real-World Assessment of DBS Outcomes Using a 16-Contact Device Capable of Multiple Independent Current Control Corneliu C. Luca, MD
12:00 PM - 01:00 PM	Abstract	3-008 - Case Report: Deep Brain Stimulation targeting the Globus Pallidus internus for Parkinson’s disease and Tourette syndrome Qiang J. Zhang, MD
12:00 PM - 01:00 PM	Abstract	3-009 - High Mortality in Early Onset Parkinson`s Disease (EOPD) Patients Eldbjorg Hustad, MD, PhD
12:00 PM - 01:00 PM	Abstract	3-010 - Impact of Race and Socioeconomic Status on the Utilization of Advanced Therapies in Parkinson’s Disease Jennifer Adrissi, MD
12:00 PM - 01:00 PM	Abstract	3-011 - Anticholinergic Use in Parkinson’s Disease: Practice Patterns in Patients with Cognitive Impairment Neil K. Shetty, MD
12:00 PM - 01:00 PM	Abstract	3-012 - Assessing Knowledge and Awareness of Parkinson’s Disease through a Community Farmer’s Market Lynda Nwabuobi, MD
12:00 PM - 01:00 PM	Abstract	3-013 - Social Determinants of Health in African Americans with Parkinson's DIsease Meagan O. Bailey, MD
12:00 PM - 01:00 PM	Abstract	3-014 - The Relationship between Serum Vitamin Levels and Dietary Vitamin Intakes in Parkinson’s Disease
12:00 PM - 01:00 PM	Abstract	3-015 - Carepartner Communication on Parkinson Disease Psychosis Sneha Mantri, MD, MS, FAAN
12:00 PM - 01:00 PM	Abstract	3-016 - Underserved Patient Access to Multidisciplinary Rehabilitation for Movement Disorders in a Single Tertiary Academic Referral Center. Ka Loong K. Au, MD
12:00 PM - 01:00 PM	Abstract	3-017 - Mindfulness Training for People with Parkinson's: Emotional Well Being, Social Support and Group Effect Barbara A. Pickut, MD
12:00 PM - 01:00 PM	Abstract	12-001 - Withdrawal of Antiepileptic Drugs After Stereotactic Laser Amygdalohippocampotomy Arjun Athreya, MD
12:00 PM - 01:00 PM	Abstract	12-002 - 3D Printed Models of Brain and Intracranial Electrodes for Epilepsy Education and Surgical Planning Pooneh Memar Ardestani, MD, PhD
12:00 PM - 01:00 PM	Abstract	12-003 - Aura Semiology as a Predictor of Outcomes Following Epilepsy Surgery Christina M. Boada, MD, MS
12:00 PM - 01:00 PM	Abstract	12-004 - Utility of MEG for Functional Language Mapping
12:00 PM - 01:00 PM	Abstract	12-005 - Cognitive and Psychiatric Outcomes Following Epilepsy Surgery Chang Brian H. Jung, MD
12:00 PM - 01:00 PM	Abstract	12-006 - Stereotactic Radiosurgery of Corpus Callosum in a Patient with Refractory Seizures: A Case Report Bahareh Sianati, MD
12:00 PM - 01:00 PM	Abstract	12-007 - Case Series: Temporal Lobe Encephalocele (TE) in Adult-Onset Drug Resistant Mesial Temporal Lobe Epilepsy (MTLE) Joseph F. Imbs IV, DO
12:00 PM - 01:00 PM	Abstract	12-008 - Predicting Depression Following Temporal Lobe Epilepsy Surgery in Adults Christine M. Doherty
12:00 PM - 01:00 PM	Abstract	12-009 - Demographic and Neuropsychological Predictors of Declining Employment Following Standard Anterior Temporal Lobectomy for the Treatment of Focal Epilepsy Patrick W. Kerns, MD, PhD
12:00 PM - 01:00 PM	Abstract	12-010 - Can We Accurately Lateralize the Epileptogenic Zone in Patients Who Have Seizure Clusters? A Study Using Stereoelectroencephalography (SEEG) Miguel Arevalo Astrada
12:00 PM - 01:00 PM	Abstract	12-011 - Stereo-EEG Seizure Localization in Patients with Medically Intractable Focal Epilepsy Associated with Schizencephaly Irina Podkorytova
12:00 PM - 01:00 PM	Abstract	6-001 - A Case of Non-alcoholic Wernicke’s Encephalopathy and Dry Beri-beri with GI Involvement Following a Period of Prolonged Gastrointestinal Illness Christina Lineback, MD
12:00 PM - 01:00 PM	Abstract	6-002 - Wernicke-Korsakoff Syndrome And Catatonia: A Case Report Caroline B. Braune, MD
12:00 PM - 01:00 PM	Abstract	6-003 - Imaging and Neuropsychological Findings in Chronic Wernicke-Korsakoff Syndrome with Isolated Involvement of the Periaqueductal Gray Matter Meredith Wicklund, MD, FAAN
12:00 PM - 01:00 PM	Abstract	6-004 - Reversible Lesion of the Splenium of the Corpus Callosum Associated with Postpartum Thiamine Deficiency Rutvij J. Shah, MD, MBBS
12:00 PM - 01:00 PM	Abstract	6-005 - Machiava Bignami: A Case of a 62 Year Old Woman with Malnutrition Who Presents with Altered Mental Status, Vision Loss with Acute Restricted Diffusion of the Splenium of the Corpus Callosum Ephrem Teklemariam, MD
12:00 PM - 01:00 PM	Abstract	6-006 - Tongue Fasciculations?Presenting?as an Early Clinical Sign of Cobalamin Deficiency Anuradha Singh, DO
12:00 PM - 01:00 PM	Abstract	6-007 - Thyrotoxic Hypokalemic Periodic Paralysis (TPP) - A hidden diagnosis Hemani Ticku, MD
12:00 PM - 01:00 PM	Abstract	6-008 - Thyrotoxicosis from Graves’ Disease Presenting with Ocular Myasthenia Gravis, Thymoma, and Demyelination Brittany M. Kasturiarachi, DO
12:00 PM - 01:00 PM	Abstract	6-009 - Grave's Disease Mimicking a Structural Myelopathy Andre Granger, MD, MBA
12:00 PM - 01:00 PM	Abstract	6-010 - Hemichorea as the Presenting Symptom of Severe Hyperglycemia Rena Sukhdeo Singh, MD
12:00 PM - 01:00 PM	Abstract	6-011 - Superficial Siderosis: A Case Of No Return Jennifer Hung, MBBS
12:00 PM - 01:00 PM	Abstract	6-012 - An Unusual Presentation of Superficial Siderosis Jinesh M. Shah, MBBS
12:00 PM - 01:00 PM	Abstract	6-013 - Establishing Ammonia Levels in Acute Onset Encephalopathy May Provide Rapid Diagnosis of Treatable Causes Karlo Toljan, MD
12:00 PM - 01:00 PM	Abstract	7-001 - Changes in Work Productivity and Interictal Burden: Results from a Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Galcanezumab in Adults with Treatment-Resistant Migraine (CONQUER) Dawn C. Buse, PhD
12:00 PM - 01:00 PM	Abstract	7-002 - Rimegepant is Effective for the Acute Treatment of Migraine in Subjects Taking Concurrent Preventive Medication: Results From 3 Phase 3 Trials Jelena M. Pavlovic, MD, PhD
12:00 PM - 01:00 PM	Abstract	7-003 - Rimegepant 75 mg Is More Effective for Migraine Than Nonsteroidal Anti-inflammatory Drugs: Post Hoc Analysis of Data From 2 Phase 3 Trials Ira M. Turner, MD
12:00 PM - 01:00 PM	Abstract	7-004 - The First, Italian, Multicenter, Real-life Study with Erenumab in the Prevention of High Frequency Episodic and Chronic Migraine Piero Barbanti, MD
12:00 PM - 01:00 PM	Abstract	7-005 - Early Onset of Efficacy With Fremanezumab in Patients With Medication Overuse and Documented Inadequate Response to 2-4 Classes of Migraine Preventive Treatments: Subgroup Analysis of the Randomized, Double-blind FOCUS Study Zaza Katsarava, MD
12:00 PM - 01:00 PM	Abstract	7-006 - Results of a Phase 1, Open-label, Single-dose, Parallel-group Study of Rimegepant 75 mg in Subjects with Hepatic Impairment
12:00 PM - 01:00 PM	Abstract	7-007 - Patient Preference and Improved Clinical Global Impression of Change with Rimegepant for the Acute Treatment of Migraine: Results from a Long-Term Open-Label Safety Study (Study 201) Christopher Jensen, PharmD
12:00 PM - 01:00 PM	Abstract	7-008 - A Randomized, Placebo-Controlled Study of Galcanezumab in Patients with Treatment-Resistant Migraine: Double-Blind Results from the CONQUER Study Michel Lanteri-Minet, MD
12:00 PM - 01:00 PM	Abstract	7-009 - Benefits of Long-Term OnabotulinumtoxinA Treatment in Chronic Migraine: Results from the COMPEL Study Andrew M. Blumenfeld, MD, FAAN
12:00 PM - 01:00 PM	Abstract	7-010 - Matching-adjusted Indirect Comparisons of Intermittent Oral Rimegepant Versus Placebo and Injectable anti-CGRP-targeted Monoclonal Antibodies Examining Monthly Migraine Days in the Treatment of Migraine Evan Popoff
12:00 PM - 01:00 PM	Abstract	7-011 - Matching-adjusted Indirect Comparisons of Intermittent Oral Rimegepant Versus Placebo and Injectable anti-CGRP Monoclonal Antibodies (mAb) Examining Health-related Quality of Life (HRQoL). Evan Popoff
12:00 PM - 01:00 PM	Abstract	7-012 - Rimegepant 75 mg Exposure, Safety, and Tolerability are Similar in Elderly and Nonelderly Adults: a Phase 1, Open-Label, Parallel-Group, Single-Dose Study
12:00 PM - 01:00 PM	Abstract	7-013 - Safety and Tolerability of Fremanezumab in Patients With Episodic and Chronic Migraine: a Pooled Analysis of Phase 3 Studies Peter J. McAllister, MD, FAAN
12:00 PM - 01:00 PM	Abstract	1-001 - Evidence that Advanced Motor Cortex Pathology in Amyotrophic Lateral Sclerosis Causes Whole Brain Systemic Effects Anson Wang, MD
12:00 PM - 01:00 PM	Abstract	1-002 - A Trial of Blood-Brain Barrier Opening in ALS using MR-Guided Focused Ultrasound Agessandro Abrahao, Jr., MD
12:00 PM - 01:00 PM	Abstract	1-003 - Brain Metabolic Correlates of Apathy in an ALS Cohort: A 18F-FDG PET Study Adriano Chio, MD, FAAN
12:00 PM - 01:00 PM	Abstract	1-005 - Quantifying Cerebral Degeneration in Amyotrophic Lateral Sclerosis Using Texture Analysis of Multimodal MRI Ekhlas Assaedi, MD
12:00 PM - 01:00 PM	Abstract	1-006 - Impedance Pharyngography to Evaluate Swallowing in Patients with Amyotrophic Lateral Sclerosis Hilda V. Gutierrez, MD
12:00 PM - 01:00 PM	Abstract	1-007 - Electrical Impedance Tomography as a Quantitative Measure of Pulmonary Function in ALS Patients Badria Munir, MD
12:00 PM - 01:00 PM	Abstract	1-008 - EEG ß-power and ß-synchrony in the Sensorimotor Network as a Potential Biomarker for Disease Severity and Progression of Motor Symptoms in ALS
12:00 PM - 01:00 PM	Abstract	1-009 - Failure of Transcranial Magnetic Stimulation of the Primary Motor Cortex to Induce a Motor evoked Potential Response in Primary Lateral Sclerosis Jeffrey B. Schachter, MD
12:00 PM - 01:00 PM	Abstract	1-010 - The Voice of Silence - The Impact of Augmentative / Alternative Communication on the Quality of Life of Patients Diagnosed with Amyotrophic Lateral Sclerosis
12:00 PM - 01:00 PM	Abstract	1-011 - A Clinical Bulbar Assessment Scale for ALS (C-BAS) Gary L. Pattee, MD
12:00 PM - 01:00 PM	Abstract	1-012 - State of the Health-related Quality of Life Evidence in Amyotrophic Lateral Sclerosis (ALS): A Systematic Literature Review
12:00 PM - 01:00 PM	Abstract	1-013 - Development of a Patient-Centered Tool for the Assessment of Muscle Cramps Hans D. Katzberg, MD, FAAN
12:00 PM - 01:00 PM	Abstract	1-014 - Electrodiagnostic Correlations with Gene Mutations in Congenital Disorders of Glycosylation (CDG): An Observational Study Noushin Jazebi, MD
12:00 PM - 01:00 PM	Abstract	10-001 - Disentangling the Neuroanatomical Basis of Olfactory Dysfunction in the General Population
12:00 PM - 01:00 PM	Abstract	10-002 - Incidence of Traumatic Brain Injury and Fall Among Patients with Alzheimer’s Disease and Impact on Mortality
12:00 PM - 01:00 PM	Abstract	10-003 - Alzheimer's Disease as a Disorder of Tryptophan Metabolism Donald F. Weaver, MD, PhD
12:00 PM - 01:00 PM	Abstract	10-004 - Apathy is Associated with Risk of Incident Dementia Among Community-Dwelling Older Adults Meredith Bock, MD
12:00 PM - 01:00 PM	Abstract	10-005 - Association of Nighttime Behaviours with Rate of Cognitive Decline in Pathologically Confirmed AD Patients: Role of Gender and Comorbidities
12:00 PM - 01:00 PM	Abstract	10-006 - Real World Evidence For Cognitive Impairment in the Long Term Care Insurance Population Anitha Rao, MD
12:00 PM - 01:00 PM	Abstract	10-007 - Impact of a National Dementia Research Program – the CCNA (Canadian Consortium on Neurodegeneration in Aging) Howard M. Chertkow, MD
12:00 PM - 01:00 PM	Abstract	10-008 - Prevalence of Cerebral Microbleeds in Patients with Idiopathic Normal Pressure Hydrocephalus and their Impact on Post-Shunt Outcome Lukas Sveikata
12:00 PM - 01:00 PM	Abstract	10-009 - Oldest Olds in Latin America: A Naturalistic Analysis Over Normal Aging and Superaging Ismael Calandri, MD
12:00 PM - 01:00 PM	Abstract	4-001 - Investigation of S-Nitrosoglutathione in Stroke: A Systematic Review and Meta-Analysis of Literature in Pre-clinical and Clinical Research Shimeng Liu, MD, PhD
12:00 PM - 01:00 PM	Abstract	4-002 - Mesenchymal Stem Cells (MSCs) Protect Hypoxic Neuronal Cells by Mitochondrial Transfer Deepaneeta Sarmah, M Pharm
12:00 PM - 01:00 PM	Abstract	4-003 - A Therapeutic Approach Using Peripheral Blood Mononuclear Cells Preconditioned by Oxygen-glucose Deprivation in Ischemic Rats Masato Kanazawa, MD, FAAN
12:00 PM - 01:00 PM	Abstract	4-004 - Biomarkers of Coagulation and Hemostatic Activation in the Post-Acute Period Effectively Rule Out Hypercoagulable States in Patients with Embolic Stroke of Undetermined Source
12:00 PM - 01:00 PM	Abstract	4-005 - Hyperviscosity in Acute Ischemic Stroke with Large Artery Steno-occlusive Disease Si Baek Lee
12:00 PM - 01:00 PM	Abstract	4-006 - Role of Blood Based Biomarkers for Predicting Outcome after Spontaneous Intracerebral Hemorrhage: Multi-Centric Prospective Cohort Study Kameshwar Prasad, MD
12:00 PM - 01:00 PM	Abstract	4-007 - Systemic Inflammation Indexes Associated with the Severity and Functional Prognosis of Ischemic Stroke Luis Fernandez
12:00 PM - 01:00 PM	Abstract	4-008 - Human plasma proteomics for biomarker discovery for ischemic stroke and TIA Supriya Ramesha, MBBS
12:00 PM - 01:00 PM	Abstract	4-009 - Border-zone Infarcts Predict Early Recurrence in Patients with Large Artery Atherosclerotic Subtype Despite Medical Treatment Alexandra Kvernland, MD
12:00 PM - 01:00 PM	Abstract	4-010 - Lower Coated-Platelet Levels, RANTES and Fibrinogen Correlate with the Number of Cerebral Microbleeds in Carotid Stenosis Sergio A. Ramirez-Salazar, MD
12:00 PM - 01:00 PM	Abstract	4-011 - Increased Total Bilirubin Levels are Associated with Hemorrhagic Transformation in Patients with Acute Ischemic Stroke
12:00 PM - 01:00 PM	Abstract	4-012 - Association of Admission Serum Low-density-Lipoprotein With Stroke Etiology Of Large-Vessel-Disease And Functional Outcome At Discharge Taha Nisar, MD
12:00 PM - 01:00 PM	Abstract	4-013 - Role of Glial Fibrillary Acidic Protein as a Biomarker in Differentiating Intracerebral Hemorrhage From Ischemic Stroke And Stroke Mimics: A Meta-Analysis
12:00 PM - 01:00 PM	Abstract	4-014 - Neutrophil-To-Lymphocyte Ratio Predicts Large Vessel Occlusion Stroke Shashvat Desai, MD
12:00 PM - 01:00 PM	Abstract	4-015 - Cavernous Malformations Secondary to PDCD10 Gene Mutation Marion Oliver, MD
12:00 PM - 01:00 PM	Abstract	4-016 - Clinical Features and Genetic Testing in Multivessel Cervical Artery Dissection Collin Culbertson, MD
12:00 PM - 01:00 PM	Abstract	4-017 - Intravenous Dimethyl Fumarate Promotes Hemoglobin Clearance in a Preclinical Hemorrhagic Stroke Model
12:00 PM - 01:00 PM	Abstract	4-018 - Role of Cytokines in Acute Ischemic Stroke Patients: Preliminary Analysis of a Prospective Database Sajid Suriya, MD
12:00 PM - 01:00 PM	Abstract	4-019 - Predict the Ischemic Volumes of Acute Stroke by Using Visual Assessment on CT Perfusion Source Imaging
12:00 PM - 01:00 PM	Abstract	4-020 - White Matter Hyperintensity Pattern Predicts Stroke Etiology Piotr Bzdyra, MD
12:00 PM - 01:00 PM	Abstract	4-021 - Cerebral Microbleeds And White Matter Hyperintensities Are Not Associated With Increased Risk of Hemorrhagic Transformation In Acute Ischemic Stroke Without Intravenous Thrombolysis Amreen Farooqui, MD
12:00 PM - 01:00 PM	Abstract	13-001 - Large Retrospective Institutional Review Identifies Novel Integrated Imaging and Clinical Markers as Early Independent Negative Prognostic Indicators of Glioblastoma Progression and Survival: A Proposed Supplement to RANO Na Tosha N. Gatson, MD, PhD, FAAN
12:00 PM - 01:00 PM	Abstract	13-002 - Outcomes and Correlations Between Legacy Quality of Life Measures (EORTC-C30/EORTC-BN20) and the Electronic Quality of Life Measuring System (NIH PROMIS) in Glioblastoma Patients Tobias Walbert, MD, PhD, FAAN
12:00 PM - 01:00 PM	Abstract	13-003 - Underrepresentation of Women and Older Patients in U.S. Glioblastoma Clinical Trials
12:00 PM - 01:00 PM	Abstract	13-004 - The Effects of Dexamethasone on Mitogen Activated Protein Kinase-14 Signaling in Diffuse Intrinsic Pontine Glioma (DIPG) Cells
12:00 PM - 01:00 PM	Abstract	13-006 - Efficacy and Toxicity of Radiation Regimens With or Without Temozolomide for CNS Lymphoma Katherine Selwa, MD
12:00 PM - 01:00 PM	Abstract	13-007 - Use Of Non-Ablative Dose Of Radiation To Enhance Delivery Of Unmodified Morpholino Oligonucleotides In A Brain Tumor Model To Silence MGMT And Enhance The Efficacy Of Chemo-Radiation Prakash Ambady, MD
12:00 PM - 01:00 PM	Abstract	13-008 - Editing of IDH1 R132H Mutation in Human Induced Pluripotent Stem Cells to Investigate Tumor Genesis in Glioma
12:00 PM - 01:00 PM	Abstract	13-009 - Estrogen Hormone Replacement Therapy in Incidental Meningioma - A Growth Rate Analysis Ryan T. Merrell, MD
12:00 PM - 01:00 PM	Abstract	13-010 - Longitudinal Perception of Prognosis of Patients with High Grade Glioma Compared to their Caregivers and Clinicians Akanksha Sharma, MD
12:00 PM - 01:00 PM	Abstract	13-011 - Hormone Levels Are Associated with Altered Brain Structure and Functional Connectivity in Prolactinomas SHUN YAO, MD
12:00 PM - 01:00 PM	Abstract	13-012 - Caregiver Perceptions of End of Life Care in Patients with High Grade Glioma John T. Fortunato, MD
12:00 PM - 01:00 PM	Abstract	13-013 - Finite Element Analysis Modeling of TTFields in Brain Metastasis According to Various Types of Cerebral Edema Sindhu Reddy Pisati, MD, MBBS
12:00 PM - 01:00 PM	Abstract	13-014 - Does the Location Matter? Characterization of the Anatomic Locations, Molecular Profiles, and Clinical Features of Gliomas Christopher P. Mackintosh
12:00 PM - 01:00 PM	Abstract	13-015 - Trends in Radiotherapeutic Management and Outcomes in Esophageal Brain Metastases Aaron Ravelo, MD
12:00 PM - 01:00 PM	Abstract	5-001 - Pediatric Upper Airway Resistance Syndrome: A Usually Missed Suspect
12:00 PM - 01:00 PM	Abstract	5-002 - Sleep Disordered Breathing in Pediatric Multiple Sclerosis Michelle J. Jaeggi, MD
12:00 PM - 01:00 PM	Abstract	5-003 - Sleep Disturbances and Idiopathic Intracranial Hypertension in Men Arina Bingeliene, MD
12:00 PM - 01:00 PM	Abstract	5-004 - Comorbidities of Patients with Restless Legs Syndrome Kevin Senanayake
12:00 PM - 01:00 PM	Abstract	5-005 - Prevalence of Restless Leg Syndrome in Skin Biopsy Proven Small Fiber Neuropathy Urvi G. Desai, MD, FAAN
12:00 PM - 01:00 PM	Abstract	5-006 - Sleep Characteristics in Active Duty Service Members with PTSD: Novel Findings and Implications Brent Jacobus II, MD
12:00 PM - 01:00 PM	Abstract	5-007 - Diffusion Tensor Imaging Evidence of Hypothalamic Injury in Traumatic Brain Injury Warfighters with Sleep Dysfunction
12:00 PM - 01:00 PM	Abstract	5-008 - Traumatic Brain Injury Warfighters with Poor Sleep have Increased Plasma Biomarkers of Neurodegeneration J. Kent Werner, Jr., MD, PhD
12:00 PM - 01:00 PM	Abstract	5-009 - Is it Time to Pay Attention to Circulating MicroRNAs as a Diagnostic Biomarker in REM Behavior Disorder? Daniela L. Giardino, MD
12:00 PM - 01:00 PM	Abstract	5-010 - Sleep Problems and Risk of All-cause Cognitive Decline or Dementia: An Updated Systematic Review and Meta-analysis Wei Xu
12:00 PM - 01:00 PM	Abstract	5-011 - Feasibility of a Home Sleep Apnea Test in a Cognitively Impaired Population David R. Colelli, MSc
12:00 PM - 01:00 PM	Abstract	5-012 - The Relationship between Sleep Disorders and Non-arteritic Anterior Ischemic Optic Neuropathy Trevor Jairam, MD

Faculty Disclosures
Eric T. Wong, MD, FAAN	Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care.
Tobias Walbert, MD, PhD, FAAN	Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Walbert has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Springworks Therapeutics . Dr. Walbert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion .
Gregory L. Barkley, MD	No disclosure on file
Matthew Brock, MD	Dr. Brock has received research support from Department of Defense, Defense Health Program, Congressionally Directed Medical Research Programs.
Hans D. Katzberg, MD, FAAN	An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX.
Rohit Das, MD, FAAN	Dr. Das has received personal compensation for serving as an employee of Oregon Health Science University. Dr. Das has received personal compensation in the range of $10,000-$49,999 for serving as a Physician Advisor with Concentra .
Clement Hamani	No disclosure on file
	No disclosure on file
Kimbra L. Kenney, MD, FAAN	Dr. Kenney has nothing to disclose.
Serge G. Gauthier, MD	Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TauRx . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly Canada . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai . Dr. Gauthier has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ENIGMA USA. Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AmyriAD. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medesis. Dr. Gauthier has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheon. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Karuna. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Otsuka . Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NovoNordisk. Dr. Gauthier has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Canada. Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sharon Francis Foundation . Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JPAD. Dr. Gauthier has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Lundbeck Foundation . Dr. Gauthier has received publishing royalties from a publication relating to health care.
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Elisabetta Pagani	Elisabetta Pagani has nothing to disclose.
Daniel Ontaneda, MD, PhD, FAAN	Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
Danish Bhatti, MD, FAAN	Dr. Bhatti has nothing to disclose.
Kedar Mahajan, MD, PhD	Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Mahajan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech.
Sheila C. Suarez, MD	Dr. Suarez has nothing to disclose.
Michelle J. Jaeggi, MD	Dr. Jaeggi has nothing to disclose.
Bianca Gunther	No disclosure on file
Marie F. Grill, MD	Dr. Grill has nothing to disclose.
Jacqueline French, MD, FAAN	Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Praxis. Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Acadia Pharmaceuticals Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Access Industries that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Acuta Capital Partners LLC that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with AFASCI Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Agrithera, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Alkermes that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Angelini Pharma S.p.A. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Autifony Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Axonis Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bain Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Beacon Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biogen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Bloom Science, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bright Minds Biosciences, Inc. that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Capsidia Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, SAB with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ceribell that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cowen that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with EcoR1 Capital that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EG 427 that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, Advisory Board with Eisai that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant/Advisory Board with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with EpiMinder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Harmony that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Ionis Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with IQVIA that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Janssen Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Jazz Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, with Livanova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with London Research & Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Longboard Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Maplight Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Medscape/Web MD that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Montara Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Mosaica Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neumarker that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neurelis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Neuropace that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neuroventis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Neurona Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Neuvarti that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Noema that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Ono Pharmaceutical that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting, Advisory Board with Otsuka that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, Advisory Board with Ovid Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LYT Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with QurAlis Corp that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Receptor Holdings, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rivervest Venture Partners that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Sage Therapeutics, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with SK Life Science that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Stream Neuroscience that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Taysha Gene Therapies that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with UCB, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with uniQure that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Xenon Pharmaceuticals that is relevant to AAN interests or activities.
Alejandro Vargas, MD, MS, FAAN	Dr. Vargas has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer U.S. LLC Pharmaceuticals.
Tanya Simuni, MD, FAAN	Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Thomas F. Scott, MD	Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme-Sanofi. Dr. Scott has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serono. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Scott has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Scott has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme.
Jorge G. Burneo, MD, MSPH, FAAN	Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, Clinical Neurology and Neurosurgery Journal. Dr. Burneo has received research support from The Jack Cowin Endowed Chair in Epilepsy Research. Dr. Burneo has received publishing royalties from a publication relating to health care. Dr. Burneo has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals.
Dean M. Wingerchuk, MD, FAAN	Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Sarah Song, MD, MPH, FAAN	Dr. Song has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN.
Rima Dafer, MD	Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Dafer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Dafer has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Anderson, Rasor, and partners.
Lawrence C. Newman, MD, FAAN	Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan . Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Newman has received publishing royalties from a publication relating to health care.
Michael R. Frankel, MD	The institution of Dr. Frankel has received research support from Nico Corporation, Inc.
Andrea Vincent	Andrea Vincent has received personal compensation for serving as an employee of Vista LifeSciences. The institution of Andrea Vincent has received research support from Medical Technology Enterprise Consortium (MTEC).
Jan O. Aasly, MD, PhD	No disclosure on file
Michael G. Dwyer III, MD, PhD	Dr. Dwyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Keystone Heart, Ltd. Dr. Dwyer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Dwyer has received research support from Novartis. The institution of Dr. Dwyer has received research support from Keystone Heart, Ltd. The institution of Dr. Dwyer has received research support from Bristol Myers Squibb. The institution of Dr. Dwyer has received research support from Roche.
Calin I. Prodan, MD	The institution of Dr. Prodan has received research support from US Department of Veterans Affairs (Merit award CX000340).
Donald F. Weaver, MD, PhD	No disclosure on file
Ryan Hays, MD, MBA, FAES, FAAN	Dr. Hays has nothing to disclose.
Jens Kuhle, MD	Dr. Kuhle has nothing to disclose.
Carmelo Graffagnino, MD	No disclosure on file
Byung-kun Kim, MD	Dr. Kim has nothing to disclose.
Srikant Rangaraju, MBBS	Dr. Rangaraju has nothing to disclose.
David W. Dodick, MD, FAAN	Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation for serving as an employee of Atria Health. Dr. Dodick has received personal compensation for serving as an employee of Thomas Jefferson University . Dr. Dodick has received personal compensation for serving as an employee of Norwegian University of Science and Technology. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Allergan. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biopharm Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inside Practice Australia. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Education Alliance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of the Pacific . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medica Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJ Healthcare. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Synapse Medical Communications. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vector Psychometrics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for WebMD. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Thomas Jefferson University. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medforce. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision HEOR. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Canadian Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Headache Cooperative of New England. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen Japan. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Axon Therapeutics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Cephalgia Group. Dr. Dodick has stock in Healint. Dr. Dodick has stock in Theranica. Dr. Dodick has stock in Aural Analytics . Dr. Dodick has stock in Epien. Dr. Dodick has stock in Matterhorn. Dr. Dodick has stock in Ontologics. Dr. Dodick has stock in Precon Health. Dr. Dodick has stock in King Devick Technologies. Dr. Dodick has stock in Nocira. Dr. Dodick has stock in Exsano. Dr. Dodick has stock in Palion. Dr. Dodick has stock in AYYA Biosciences. Dr. Dodick has stock in Perfood. Dr. Dodick has stock in Cephalgia Group. Dr. Dodick has stock in Atria Health. Dr. Dodick has stock in Man and Science. Dr. Dodick has stock in Eigenlyfe. An immediate family member of Dr. Dodick has stock in ScotiaLyfe. Dr. Dodick has stock in Axon Therapeutics. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.
Richard A. Rudick, MD, FAAN	Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care.
Mario Masellis, MD	Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda Therapeutics. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Masellis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave Life Sciences. The institution of Dr. Masellis has received research support from Canadian Institutes of Health Research. The institution of Dr. Masellis has received research support from Ontario Brain Institute. The institution of Dr. Masellis has received research support from Weston Brain Institute. The institution of Dr. Masellis has received research support from Washington University. The institution of Dr. Masellis has received research support from Alector. Dr. Masellis has received publishing royalties from a publication relating to health care.
Sandra E. Black, MD, FAAN	Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Black has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Limited . Dr. Black has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Black has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Black has received research support from Hoffmann-La Roche. The institution of Dr. Black has received research support from Biogen. The institution of Dr. Black has received research support from GE Healthcare. The institution of Dr. Black has received research support from Eli Lilly. The institution of Dr. Black has received research support from Genentech. The institution of Dr. Black has received research support from NovoNordisk. The institution of Dr. Black has received research support from UCB Biopharma. The institution of Dr. Black has received research support from Alkahest Inc. The institution of Dr. Black has received research support from University of Southern California - AHEAD 3-45 Study.
Niels Bergsland	Prof. Bergsland has nothing to disclose.
Murali Ramanathan, PhD	The institution of Dr. Ramanathan has received research support from DoD. Dr. Ramanathan has received publishing royalties from a publication relating to health care.
Barbara Bumstead, NP	Ms. Bumstead has nothing to disclose.
Arielle M. Kurzweil, MD, FAAN	Dr. Kurzweil has nothing to disclose.
Jeffrey A. Wilken, PhD	No disclosure on file
Gregg G. Blevins, MD, FRCP(C)	Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffman La-roche. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Blevins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen Idec. The institution of Dr. Blevins has received research support from Novartis. Dr. Blevins has received research support from Hoffman La-Roche. The institution of Dr. Blevins has received research support from EMD Serono. Dr. Blevins has received research support from Biogen Idec. The institution of Dr. Blevins has received research support from MS society of Canada. The institution of Dr. Blevins has received research support from Canadian Institutes of Health Research .
Jelena M. Pavlovic, MD, PhD	Dr. Pavlovic has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Pavlovic has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Laurel J. Cherian, MD, FAAN	The institution of Dr. Cherian has received research support from NIH.
Michael R. Sperling, MD, FAAN	Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medscape. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for International Medical Press. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Projects for Knowledge. The institution of Dr. Sperling has received research support from SK Life Science. The institution of Dr. Sperling has received research support from UCB Pharma . The institution of Dr. Sperling has received research support from Takeda. The institution of Dr. Sperling has received research support from Neurelis. The institution of Dr. Sperling has received research support from Engage Therapeutics . The institution of Dr. Sperling has received research support from Medtronic. The institution of Dr. Sperling has received research support from Cavion. The institution of Dr. Sperling has received research support from Xenon Pharma. The institution of Dr. Sperling has received research support from Cerevel. The institution of Dr. Sperling has received research support from National Institutes of Health . The institution of Dr. Sperling has received research support from DARPA. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received publishing royalties from a publication relating to health care. Dr. Sperling has received personal compensation in the range of $500-$4,999 for serving as a Vice President with Epilepsy Consortium .
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Federica Esposito	Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Federica Esposito has received research support from Italian MS Society. The institution of Federica Esposito has received research support from Italian Ministry of Health. The institution of Federica Esposito has received research support from ERA Net. The institution of Federica Esposito has received research support from European Commission. Federica Esposito has received intellectual property interests from a discovery or technology relating to health care.
Larisa Yedigarova	Larisa Yedigarova has received personal compensation for serving as an employee of AbbVie. Larisa Yedigarova has received stock or an ownership interest from AbbVie.
Andrew Zillgitt, DO	Dr. Zillgitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Zillgitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Zillgitt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB. Dr. Zillgitt has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. Dr. Zillgitt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Zillgitt has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Lifescience.
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Jens Volkmann, MD	Jens Volkmann, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceregate. Jens Volkmann, MD has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Newronika. Jens Volkmann, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific. Jens Volkmann, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Jens Volkmann, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bial. Jens Volkmann, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Jens Volkmann, MD has received research support from DFG. The institution of Jens Volkmann, MD has received research support from BMBF. The institution of Jens Volkmann, MD has received research support from Boston Scientific. The institution of Jens Volkmann, MD has received research support from Medtronic.
Wengui Yu, MD, PhD	Dr. Yu has nothing to disclose.
Guenther Deuschl, MD, FAAN	Dr. Deuschl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Deuschl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific Cavion Functional Neuromodulation. The institution of Dr. Deuschl has received research support from Medtronic. Dr. Deuschl has received publishing royalties from a publication relating to health care.
Meredith Bock, MD	The institution of Dr. Bock has received research support from American Academy of Neurology. The institution of Dr. Bock has received research support from Michael J Fox Foundation.
Maciej M. Mrugala, MD, PhD, MPH, FAAN	Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Mrugala has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities.
Kristine Yaffe, MD	Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Robert T. Naismith, MD, FAAN	Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squib. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Naismith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genzyme. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celltrion. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impaact-Bio. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch.
Shreyansh Shah, MD	No disclosure on file
Laura Cacciaguerra, MD, PhD	Dr. Cacciaguerra has nothing to disclose.
Beomseok Jeon, MD	Dr. Jeon has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Jeon has received research support from peptron. The institution of Dr. Jeon has received research support from zemvax & kael. Dr. Jeon has received personal compensation in the range of $500-$4,999 for serving as a expert panel with Aspen Neuroscience.
Mona Shahbazi	No disclosure on file
Alessandro Meani	Alessandro Meani has nothing to disclose.
Hafiz Elahi, MD	No disclosure on file
Nicholas D. Osteraas, MD	Dr. Osteraas has nothing to disclose.
Peter A. Calabresi, MD, FAAN	Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. An immediate family member of Dr. Calabresi has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MyMD. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Myelin Repair Foundation. The institution of Dr. Calabresi has received research support from Genentech. Dr. Calabresi has received publishing royalties from a publication relating to health care. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Grant reveiwer with Myelin Repair Foundation. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker for CME with NYAS. Dr. Calabresi has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Academic CME.
Howard Feldman, MD, FAAN	The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen Research & Development LLC. The institution of Dr. Feldman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tau Consortium. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Vivoryon Therapeutics. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from US National Institute of Health NIH/NIA. The institution of Dr. Feldman has received research support from Allyx Pharmaceuticals. The institution of Dr. Feldman has received research support from Canadian Institutes of Health Research . Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Medical Advisory Council with Association for Frontotemporal Degeneration (AFTD) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a International Scientific Advisory Board with Translating Research in Elder Care (TREC) that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Royal Society of Canada that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter with Banner Health that is relevant to AAN interests or activities. Dr. Feldman has a non-compensated relationship as a Conference, Presenter, Manuscript Author with University of British Columbia that is relevant to AAN interests or activities.
Osamu Onodera, MD	Dr. Onodera has nothing to disclose.
Takayoshi Shimohata, MD, FAAN	Dr. Shimohata has nothing to disclose.
Ellen M. Mowry, MD, FAAN	Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Octave. Dr. Mowry has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SetPoint. The institution of Dr. Mowry has received research support from Genentech/Roche. The institution of Dr. Mowry has received research support from Biogen. Dr. Mowry has received publishing royalties from a publication relating to health care.
Mark Gudesblatt, MD	The institution of Dr. Gudesblatt has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for genentech. The institution of Dr. Gudesblatt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Kumar Rajamani, MD, FAAN	Dr. Rajamani has nothing to disclose.
Tanya J. Lehky, MD	Dr. Lehky has nothing to disclose.
Alexander Yu	No disclosure on file
Marijean Buhse	Marijean Buhse has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Maria Petracca, PhD	Dr. Petracca has nothing to disclose.
James Conners, MD	The institution of Dr. Conners has received research support from nih.
Wayne W. Feng, MD, FAAN	Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Namsa. The institution of Dr. Feng has received research support from NIH. The institution of Dr. Feng has received research support from American heart association . The institution of Dr. Feng has received research support from Ipsen.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Anat Achiron, MD, PhD, FAAN	Dr. Achiron has nothing to disclose.
Monique M. Breteler, MD, PhD	No disclosure on file
Courtney E. McIlduff, MD	The institution of Dr. McIlduff has received research support from NIH - R21NSNS118434. The institution of Dr. McIlduff has received research support from NIH - R01MH111875. The institution of Dr. McIlduff has received research support from Blavatnik Family Fund. Dr. McIlduff has received publishing royalties from a publication relating to health care.
Kameshwar Prasad, MD	The institution of Prof. Prasad has received research support from Government of India Departments of Health Research and Biotechnology.
Ioannis Karakis, MD, FAAN	Dr. Karakis has received personal compensation for serving as an employee of Emory University School of Medicine. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Karakis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Karakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epitel. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hill Ward Henderson.
Dawn C. Buse, PhD	Dr. Buse has received personal compensation for serving as an employee of Vector Psychometric Group. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranicsa. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie-Allergan. Dr. Buse has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Buse has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Pain and Headache Reports. The institution of Dr. Buse has received research support from Amgen. The institution of Dr. Buse has received research support from FDA. The institution of Dr. Buse has received research support from National Headache Foundation.
Cynthia L. Sullivan, PhD	No disclosure on file
Andrew Lim, MD	Dr. Lim has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai Canada.
Kan Ding, MD	The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Ira M. Turner, MD	Dr. Turner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan, Amgen, Novartis, Teva, Lilly, Lundbeck, Biohaven,Impel. Dr. Turner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen, Teva, Allergan, Biohaven, Lilly, Lundbeck, Theranica, Revance. Dr. Turner has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan, Amgen, Biohaven, Teva, Novartis, Lundbeck, Lilly. The institution of Dr. Turner has received research support from Allergan, Amgen, Biohaven, Lilly, Lundbeck, Theranica.
Tomas H. Holmlund, MD, FAAN	No disclosure on file
Friedemann Paul	Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann-La Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb GmbH & Co. KGaA (BMS. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Paul has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for F&U Confirm. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb GesmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MICE Service. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for VINDICO medical education. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Beijing Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sandoz Internation GmbH. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Thailand. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche . Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology, Neuroimmunology&Neuroinflammation.
Kunio Nakamura, PhD	Dr. Nakamura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INmune Bio. The institution of Dr. Nakamura has received research support from Biogen. The institution of Dr. Nakamura has received research support from PCORI. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from Novartis. The institution of Dr. Nakamura has received research support from DOD. Dr. Nakamura has received intellectual property interests from a discovery or technology relating to health care.
Klemens Ruprecht, MD	Dr. Ruprecht has received research support from European Union (821283-2). Dr. Ruprecht has received research support from Merck Serono. Dr. Ruprecht has received research support from Stiftung Charite. Dr. Ruprecht has received research support from Arthur Arnstein Foundation. Dr. Ruprecht has received publishing royalties from a publication relating to health care.
Elizabeth Fisher	Elizabeth Fisher has received personal compensation for serving as an employee of Biogen. Elizabeth Fisher has stock in Biogen. Elizabeth Fisher has received intellectual property interests from a discovery or technology relating to health care.
Loredana Storelli	Loredana Storelli has nothing to disclose.
Shay Menascu, MD	No disclosure on file
Natalia Murinova, MD, FAAN	Dr. Murinova has nothing to disclose.
Ashutosh P. Jadhav, MD, FAAN	Dr. Jadhav has nothing to disclose.
Alex Rovira	Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofy. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Alex Rovira has stock in Tensor Medical.
Arturo Garay, MD	No disclosure on file
Judith Bellmann-Strobl, MD	Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Judith Bellmann-Strobl, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Judith Bellmann-Strobl, MD has received research support from Bayer. The institution of Judith Bellmann-Strobl, MD has received research support from NEMOS.
Michel Lanteri-Minet, MD	Dr. Lanteri-Minet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Lanteri-Minet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Lanteri-Minet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Lanteri-Minet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Lanteri-Minet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Lanteri-Minet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion. Dr. Lanteri-Minet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Perfood. Dr. Lanteri-Minet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UPSA. Dr. Lanteri-Minet has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IPSEN. Dr. Lanteri-Minet has received publishing royalties from a publication relating to health care.
Kresimir Dolic, MD	No disclosure on file
Amir A. Mbonde, MD	Dr. Mbonde has nothing to disclose.
Carrie M. Hersh, DO, MSc, FAAN	Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech_GN41791. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb . Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Hersh has received research support from Biogen. The institution of Dr. Hersh has received research support from Novartis. The institution of Dr. Hersh has received research support from Genentech_GN41791. The institution of Dr. Hersh has received research support from PCORI. The institution of Dr. Hersh has received research support from Bristol Myers Squibb.
Alyx B. Porter, MD, FAAN	Dr. Porter has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to AAN interests or activities.
Miguel J. Lainez, MD, PhD, FAAN	No disclosure on file
Masato Kanazawa, MD, FAAN	Dr. Kanazawa has nothing to disclose.
Lorne H. Zinman, MD	Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, MTP, AB Science, Cytokinetics, Amylyx. Dr. Zinman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylyx.
Wim Van Hecke, PhD	Dr. Van Hecke has received personal compensation for serving as an employee of icometrix.
John M. Bertoni, MD, PhD, FAAN	Dr. Bertoni has nothing to disclose.
Inderjit Singh, PhD	No disclosure on file
Juan F. Gongora Rivera, MD, MD, MSc, PhD	Dr. Gongora Rivera has nothing to disclose.
Stephen M. Rao, PhD	Stephen M. Rao, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Stephen M. Rao, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the International Neuropsychological Society. Stephen M. Rao, PhD has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Psychologist. The institution of Stephen M. Rao, PhD has received research support from Biogen. Stephen M. Rao, PhD has received intellectual property interests from a discovery or technology relating to health care.
Dejan Jakimovski, MD, PhD	Dr. Jakimovski has nothing to disclose.
Lonni Schultz, PhD	Dr. Schultz has nothing to disclose.
Lauren B. Krupp, MD, FAAN	Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Alexander U. Brandt, MD	No disclosure on file
Paolo Preziosa	Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Aarushi Suneja, MD	Dr. Suneja has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Suneja has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Yury Seliverstov, MD, PhD	No disclosure on file
Muhammad F. Ishfaq, MD	Dr. Ishfaq has nothing to disclose.
Shimeng Liu, MD, PhD	No disclosure on file
Erin Smith, MD	Dr. Smith has nothing to disclose.
Qiang J. Zhang, MD	The institution of Dr. Zhang has received research support from NIH/NIA.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Seward B. Rutkove, MD, FAAN	Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Andrew M. Blumenfeld, MD, FAAN	Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Axsome. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Axon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Cedar Sinai. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan/Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AXSOME.
Jonathan Jagid	Jonathan Jagid has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Miami Dade County State Attorneys office. The institution of Jonathan Jagid has received research support from Boston Scientific.
Corneliu C. Luca, MD	Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific. Dr. Luca has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Signant Health. Dr. Luca has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott.
Michael Barbe	No disclosure on file
Christopher M. Parres, MD	No disclosure on file
Andrea Kuehn	Andrea Kuehn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic. Andrea Kuehn has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Rachel Brandstadter, MD	Dr. Brandstadter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Theresa A. Zesiewicz, MD	Dr. Zesiewicz has received personal compensation for serving as an employee of Medscape. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lexeo. Dr. Zesiewicz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Steminent. Dr. Zesiewicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Zesiewicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care. Dr. Zesiewicz has received intellectual property interests from a discovery or technology relating to health care.
Robert J. Fox, MD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Aaron Lord, MD	Dr. Lord has nothing to disclose.
James F. Sumowski	Mr. Sumowski has nothing to disclose.
A. Blake Buletko, MD	Dr. Buletko has nothing to disclose.
Viviane T. Carvalho, MD	Dr. Carvalho has nothing to disclose.
Pooja Khatri, MD, FAAN	Dr. Khatri has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lumosa. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Khatri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basking Biosciences. Dr. Khatri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Silvercreek. The institution of Dr. Khatri has received research support from NIH/NINDS. The institution of Dr. Khatri has received research support from AHA. The institution of Dr. Khatri has received research support from Cerenovus. Dr. Khatri has received publishing royalties from a publication relating to health care.
Claudio Gobbi, MD	Dr. Gobbi has nothing to disclose.
Ian J. Butler, MD	No disclosure on file
Dileep R. Yavagal, MD, FAAN	Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Pedro Mancias, MD	No disclosure on file
James R. Williams III, PhD	Dr. Williams has received personal compensation for serving as an employee of Biogen. Dr. Williams has received stock or an ownership interest from Biogen.
Patricia C. Dugan, MD	No disclosure on file
Adam M. Willis, MD	The institution of Dr. Willis has received research support from Air Force. Dr. Willis has received intellectual property interests from a discovery or technology relating to health care.
Roshini Jain	Roshini Jain has received personal compensation for serving as an employee of Boston Scientific. Roshini Jain has received stock or an ownership interest from Boston Scientific.
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept.
Mark I. Boulos, MD, FRCPC, CSCN(EEG), MSc	Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision AQ. Dr. Boulos has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Techspert. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sleep Medicine (journal). The institution of Dr. Boulos has received research support from Canadian Institutes of Health Research. The institution of Dr. Boulos has received research support from RLS Foundation. The institution of Dr. Boulos has received research support from Temerty Centre for AI Research and Education in Medicine (T-CAIREM). The institution of Dr. Boulos has received research support from Heart & Stroke Foundation of Canada. The institution of Dr. Boulos has received research support from Alternative Funding Plan from the Academic Health Sciences Centres of Ontario. The institution of Dr. Boulos has received research support from StrokeCog. The institution of Dr. Boulos has received research support from McLaughlin Centre for Molecular Medicine . The institution of Dr. Boulos has received research support from Zoll Itamar. The institution of Dr. Boulos has received research support from Toronto Dementia Research Alliance. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Jazz Pharmaceuticals. Dr. Boulos has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Lundbeck.
Osvaldo J. Nascimento, MD, PhD, FAAN	Dr. Nascimento has nothing to disclose.
Nancy M. Nealon, MD	Dr. Nealon has nothing to disclose.
Neha Safi, MD	No disclosure on file
Drew S. Kern, MD, FAAN	Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Kern has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. The institution of Dr. Kern has received research support from Boston Scientific. The institution of Dr. Kern has received research support from AbbVie Pharmaceticals. Dr. Kern has received research support from Medtronic.
Howard L. Weiner, MD	Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Urvi G. Desai, MD, FAAN	Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Desai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fulcrum. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Desai has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Mona Sazgar, MD	Dr. Sazgar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sazgar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xenon. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Sazgar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eisai. Dr. Sazgar has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Lifesciences. The institution of Dr. Sazgar has received research support from UCB. Dr. Sazgar has received publishing royalties from a publication relating to health care.
Sarah Lee, MD	Dr. Lee has nothing to disclose.
Wai Wai Miller, MD	No disclosure on file
Catherine Hassett, MD	Dr. Hassett has nothing to disclose.
Richard Butterfield	No disclosure on file
Anand Viswanathan, MD	Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam Pharmaceuticals. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Viswanathan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals.
Sharon Yeatts	The institution of Sharon Yeatts has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Sharon Yeatts has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart/American Stroke Association.
Shelly K. Weiss, MD	No disclosure on file
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen. The institution of Dr. Krieger has received research support from Sanofi.
Michelle Fabian, MD, FAAN	Dr. Fabian has nothing to disclose.
Benjamin R. Brooks, MD, FAAN	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with American Academy of Neurology that is relevant to AAN interests or activities.
Sneha Pandya	No disclosure on file
Neelum T. Aggarwal, MD	Dr. Aggarwal has nothing to disclose.
Susan Gauthier, DO	Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gauthier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Gauthier has received research support from Genentech.
Claire Riley, MD, FAAN	Dr. Riley has received personal compensation for serving as an employee of AstraZeneca. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta Bio. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Riley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics.
Cristina Granziera, MD, PhD	The institution of Prof. Granziera has received research support from Novartis. The institution of Prof. Granziera has received research support from Hoffmann La Roche. The institution of Prof. Granziera has received research support from Genzyme Sanofi. The institution of Prof. Granziera has received research support from Biogen.
Agnes Kowalska, MD	Dr. Kowalska has nothing to disclose.
Umberto Manera, MD	Dr. Manera has nothing to disclose.
Sylvia Klineova, MD	Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Klineova has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Klineova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Caroline B. Braune, MD	Dr. Braune has nothing to disclose.
Koto Ishida, MD, FAAN	Dr. Ishida has received publishing royalties from a publication relating to health care.
Anson Wang, MD	Dr. Wang has nothing to disclose.
Cristina Moglia	Cristina Moglia has nothing to disclose.
Anitha Rao, MD	An immediate family member of Dr. Rao has received personal compensation for serving as an employee of Abbvie. Dr. Rao has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Neurovision. Dr. Rao has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Virtusense. Dr. Rao has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. An immediate family member of Dr. Rao has stock in Abbvie. Dr. Rao has a non-compensated relationship as a Executive Board of Directors with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Andrea C. Wasilewski, MD	Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals .
Aaron E. Miller, MD, FAAN	Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Jose L. Torres, MD	Dr. Torres has nothing to disclose.
David S. Liebeskind, MD, FAAN	Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Shyam Prabhakaran, MD	Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Shahamat Tauhid, MD	Dr. Tauhid has nothing to disclose.
Victoria Leavitt, PhD, FAAN	Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Leavitt has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Leavitt has received research support from National Institutes of Health. The institution of Dr. Leavitt has received research support from National Multiple Sclerosis Society. The institution of Dr. Leavitt has received research support from Department of Defense. Dr. Leavitt has received intellectual property interests from a discovery or technology relating to health care.
Carlos A. Perez, MD	Dr. Perez has received personal compensation for serving as an employee of Sanofi-Genzyme.
Kallol K. Set, MD	Dr. Set has nothing to disclose.
Jennifer Hung, MBBS	No disclosure on file
Jonathan D. Zurawski, MD	The institution of Dr. Zurawski has received research support from The Race to Erase MS Foundation. The institution of Dr. Zurawski has received research support from Novartis Pharmaceuticals. The institution of Dr. Zurawski has received research support from I-Mab Biopharma . The institution of Dr. Zurawski has received research support from Elizabeth A. Kremer MS Research Foundation. The institution of Dr. Zurawski has received research support from Novartis.
Steven M. Albert, PhD, MSPH, FAAN	No disclosure on file
Peter J. McAllister, MD, FAAN	Dr. McAllister has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for pfizer. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck.
Fabio Frediani	No disclosure on file
Nimish A. Mohile, MD, FAAN	The institution of Dr. Mohile has received research support from Novocure.
Shadi Yaghi, MD	Dr. Yaghi has nothing to disclose.
Andrea Calvo, MD, PhD, FAAN	Dr. Calvo has nothing to disclose.
Ludwig Kappos, MD, FAAN	Dr. Kappos has nothing to disclose.
Donald P. Smith	No disclosure on file
Alexandra Kvernland, MD	Dr. Kvernland has nothing to disclose.
Arina Bingeliene, MD	No disclosure on file
Fred D. Lublin, MD, FAAN	Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Gilles Allali, MD, PhD	Dr. Allali has nothing to disclose.
Michael W. Devereaux, MD, FAAN	Dr. Devereaux has received personal compensation for serving as an employee of DigiTrace part of Sleepmed. Dr. Devereaux has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Kevin Trangle and Associates.
Brian C. Healy	The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
David Bradley, MD	Dr. Bradley has nothing to disclose.
Mohsin Maqbool, MD	No disclosure on file
Thanh Nguyen	No disclosure on file
Collin Culbertson, MD	Dr. Culbertson has nothing to disclose.
Babak Razavi, MD, PhD	Dr. Razavi has stock in CortexXus. The institution of Dr. Razavi has received research support from Neuropace.
Ilana B. Katz Sand, MD	The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with American Academy of Neurology.
Oezguer Yaldizli, MD	Dr. Yaldizli has nothing to disclose.
Yi Wang, PhD	Prof. Wang has received intellectual property interests from a discovery or technology relating to health care.
Nan Zhang	Nan Zhang has nothing to disclose.
Na Tosha N. Gatson, MD, PhD, FAAN	Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Silicon Biosystems. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharmaceuticals. Dr. Gatson has received publishing royalties from a publication relating to health care. Dr. Gatson has a non-compensated relationship as a Board Member with Society for Equity in Neurosciences (SEQUINS) that is relevant to AAN interests or activities.
Lilit Mnatsakanyan, MD	Dr. Mnatsakanyan has nothing to disclose.
Vladimir Coric	Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
Jens Wuerfel, MD	Dr. Wuerfel has received personal compensation for serving as an employee of MIAC AG. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Actelion. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Jack J. Lin, MD	Dr. Lin has received stock or an ownership interest from StimScience. Dr. Lin has received stock or an ownership interest from IFovea.
Ulrike Kaunzner, MD	Dr. Kaunzner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Kaunzner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medlearning.
Antonio Canosa	Antonio Canosa has nothing to disclose.
Rohit Bakshi, MD, FAAN	Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Bakshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Bakshi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neuroimaging. The institution of Dr. Bakshi has received research support from Bristol Myers Squibb. The institution of Dr. Bakshi has received research support from EMD Serono. The institution of Dr. Bakshi has received research support from Novartis.
Adam De Havenon, MD, FAAN	Dr. De Havenon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. De Havenon has or had stock in Certus.Dr. De Havenon has or had stock in TitinKM. The institution of Dr. De Havenon has received research support from NIH/NINDS. Dr. De Havenon has received publishing royalties from a publication relating to health care.
Timothy K. Vartanian, MD, PhD	Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Vartanian has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Vartanian has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tisch MS Center. Dr. Vartanian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen.
Michael S. Okun, MD, FAAN	Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Lara Jehi, MD	Dr. Jehi has nothing to disclose.
Roberta Messina, MD, PhD	Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Organon. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Messina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli Lilly.
Saef Izzy, MD, FAAN	The institution of Dr. Izzy has received research support from NINDS. The institution of Dr. Izzy has received research support from The Gillian Reny Stepping Strong Center for Trauma Innovation. Dr. Izzy has received publishing royalties from a publication relating to health care.
Catherine Kopil	No disclosure on file
Piero Barbanti, MD	Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Fondazione Ricerca e Salute. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Barbanti has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Visufarma. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Assosalute. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eli-Lilly. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Organon. Dr. Barbanti has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Barbanti has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TEVA. Dr. Barbanti has received publishing royalties from a publication relating to health care.
Sneha Mantri, MD, MS, FAAN	Dr. Mantri has received personal compensation for serving as an employee of Parkinson's Foundation. Dr. Mantri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. The institution of Dr. Mantri has received research support from The Michael J Fox Foundation for Parkinson Research.
Jeffrey B. Schachter, MD	Dr. Schachter has nothing to disclose.
David O. Kamson, MD	The institution of Dr. Kamson has received research support from Maryland Cigarette Restitution Fund. The institution of Dr. Kamson has received research support from AACR. The institution of Dr. Kamson has received research support from Metavivor. The institution of Dr. Kamson has received research support from NIH.
Catello Vollono	Catello Vollono has nothing to disclose.
John T. Fortunato, MD	No disclosure on file
Noushin Jazebi, MD	Dr. Jazebi has nothing to disclose.
Christina Lineback, MD	Dr. Lineback has nothing to disclose.
Matthew Smith	Matthew Smith has nothing to disclose.
Ana Suller Marti, MD	Dr. Suller Marti has nothing to disclose.
Ephrem Teklemariam, MD	Dr. Teklemariam has nothing to disclose.
Mudassir Farooqui, MD	Dr. Farooqui has nothing to disclose.
Xiaoping Ning	Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical . Ms. Ning has received personal compensation for serving as an employee of Teva Pharmaceutical.
Andrew Schroeder, MD	No disclosure on file
Sabra M. Abbott, MD, PhD	Dr. Abbott has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Sleep Medicine. The institution of Dr. Abbott has received research support from NIH. Dr. Abbott has received publishing royalties from a publication relating to health care.
Andre Granger, MD, MBA	Dr. Granger has nothing to disclose.
Meredith Wicklund, MD, FAAN	The institution of Dr. Wicklund has received research support from Arizona Alzheimer's Consortium. The institution of Dr. Wicklund has received research support from NIH.
Rodrigo Zepeda, MD	The institution of Dr. Zepeda has received research support from NIH.
Surekha Dabla, MD	Dr. Dabla has nothing to disclose.
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Edward A. Neuwelt, MD	No disclosure on file
Tatiana Plavina, PhD	No disclosure on file
Bradley Lega, MD	The institution of Bradley Lega has received research support from NIH.
Christopher Jensen, PharmD	Dr. Jensen has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Jensen has stock in Biohaven Pharmaceuticals.
Julie Robillard	No disclosure on file
Arjun Athreya, MD	Dr. Athreya has nothing to disclose.
Miguel Arevalo Astrada	Miguel Arevalo Astrada has nothing to disclose.
Andriy Yabluchanskiy	Andriy Yabluchanskiy has nothing to disclose.
Aaron Ravelo, MD	Dr. Ravelo has nothing to disclose.
Sasha Alick-Lindstrom, MD, MPH FACNS, FAES, FAAN	Dr. Alick-Lindstrom has nothing to disclose.
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Sanjay Kalra, MD	The institution of Dr. Kalra has received research support from Brain Canada Foundation. The institution of Dr. Kalra has received research support from Biogen.
Fadi B. Nahab, MD	Dr. Nahab has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal Consultation. Dr. Nahab has received intellectual property interests from a discovery or technology relating to health care.
Egilius L. Spierings, MD, PhD	Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Manistee. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Spierings has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Peter Bede, MD, PhD	Dr. Bede has nothing to disclose.
Devon Conway, MD	Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Conway has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Conway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Conway has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Conway has received research support from Novartis. The institution of Dr. Conway has received research support from BMS. The institution of Dr. Conway has received research support from Biogen.
Livia D. Sousa, MD	Dr. Sousa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer,Merck,Novartis,Biogen,Saniofi,Roche.
Robyn Busch	Robyn Busch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Inc.. Robyn Busch has received research support from National Institutes of Health. Robyn Busch has received research support from American Epilepsy Society. Robyn Busch has received research support from Cleveland Clinic. Robyn Busch has received research support from Ohio Department of Higher Education. Robyn Busch has received intellectual property interests from a discovery or technology relating to health care.
Atif Zafar, MD	Dr. Zafar has nothing to disclose.
Ibrahim Laleka	No disclosure on file
Ka Loong K. Au, MD	Dr. Au has nothing to disclose.
David Clayton	David Clayton has received personal compensation for serving as an employee of Genentech/Roche. David Clayton has received stock or an ownership interest from Roche. An immediate family member of David Clayton has received publishing royalties from a publication relating to health care.
Matilde Inglese, MD, PhD	Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
George Dale	George Dale has nothing to disclose.
Jon T. Willie, MD, PhD	Jon T. Willie, MD, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for AiM Medical. Jon T. Willie, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medtronic. Jon T. Willie, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neuropace.
Daniel Golan, MD	No disclosure on file
Kathryn Fitzgerald, PhD	Dr. Fitzgerald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Setpoint Medical. The institution of Dr. Fitzgerald has received research support from NIH. The institution of Dr. Fitzgerald has received research support from National MS Society.
Alexander Doyle, MD	Dr. Doyle has nothing to disclose.
Timothy E. Lotze, MD, FAAN	Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care. Dr. Lotze has received publishing royalties from a publication relating to health care.
Jose A. Obeso, MD	No disclosure on file
Jesper Hagemeier	No disclosure on file
Hina N. Dave, MD	Dr. Dave has nothing to disclose.
Agessandro Abrahao, Jr., MD	Dr. Abrahao has nothing to disclose.
Eyal Muscal	Eyal Muscal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for sobi. An immediate family member of Eyal Muscal has stock in pfizer.
Sergio A. Ramirez-Salazar, MD	Dr. Ramirez-Salazar has nothing to disclose.
Robert Croop, MD	Dr. Croop has received personal compensation for serving as an employee of Biohaven Pharmaceuticals, Inc. Dr. Croop has received personal compensation for serving as an employee of Pfizer Inc.. Dr. Croop has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Collima LLC. Dr. Croop has stock in Biohaven Pharmaceutical Holding Co Ltd. Dr. Croop has stock in Biohaven Ltd.. Dr. Croop has stock in Actio Biosciences, Inc. . Dr. Croop has received research support from Pfizer Inc. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care. Dr. Croop has received intellectual property interests from a discovery or technology relating to health care.
Kenneth Rockwood	No disclosure on file
Melanie D. Ward, MD	Dr. Ward has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Ward has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. Ward has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ward has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Ward has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. The institution of Dr. Ward has received research support from Genentech.
Nupur Brahmbhatt, MD	No disclosure on file
Supriya Ramesha, MBBS	Dr. Ramesha has nothing to disclose.
Shitiz K. Sriwastava, MBBS	Dr. Sriwastava has nothing to disclose.
David G. Munoz, MD	No disclosure on file
Ryan T. Merrell, MD	No disclosure on file
Kathryn P. Moore, MD	Dr. Moore has a non-compensated relationship as a Medical Advisory Board with HD Reach that is relevant to AAN interests or activities.
Yi Jing Zhao, MD	The institution of Dr. Zhao has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Zhao has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for DKSH. The institution of Dr. Zhao has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva.
Vinaykumar Puduvalli, MD	Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Insightec . Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. An immediate family member of Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Newave . Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Puduvalli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Insightec, Novocure, Bayer, Servier, . An immediate family member of Dr. Puduvalli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Newave . Dr. Puduvalli has stock in Gilead. Dr. Puduvalli has stock in Moderna. The institution of Dr. Puduvalli has received research support from Merck, Servier, Bexion, Karyopharm, Samus therapeutics.
Syed A. Quadri, MD	Dr. Quadri has nothing to disclose.
Jinesh M. Shah, MBBS	No disclosure on file
Ahmad Mahadeen, MD	Dr. Mahadeen has nothing to disclose.
Bruno Mercuri, MD, PhD	No disclosure on file
Muhib Khan, MD, FAAN	The institution of Dr. Khan has received research support from Mayo Clinic Education Grant . The institution of Dr. Khan has received research support from Mayo Clinic Small Grants .
Verena Ramirez Campos, MD	Dr. Ramirez Campos has received personal compensation for serving as an employee of teva.
Meagan O. Bailey, MD	Dr. Bailey has nothing to disclose.
Amy Nowacki	Amy Nowacki has nothing to disclose.
Stefan Dukic	No disclosure on file
Ryna Then, MD, FAAN	Dr. Then has nothing to disclose.
Robert Gross	No disclosure on file
J. H. Harvey, DO	Dr. Harvey has received personal compensation for serving as an employee of Neuralogix. Dr. Harvey has received personal compensation for serving as an employee of Integris . Dr. Harvey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Harvey has stock in Epiminder.
Sankar P. Gorthi, MD, FAAN	Dr. Gorthi has nothing to disclose.
Jared Srinivasan	No disclosure on file
Ghazala Perven, MD	Dr. Perven has nothing to disclose.
Fan Wu, PhD	No disclosure on file
Zoya Zaeem, MD	Dr. Zaeem has nothing to disclose.
Howard M. Chertkow, MD	The institution of Dr. Chertkow has received research support from Hoffmann-La Roche Limited. The institution of Dr. Chertkow has received research support from Anavex Life Sciences. The institution of Dr. Chertkow has received research support from Alector Co.. The institution of Dr. Chertkow has received research support from Lilly.
Seyed M. Mirsattari, MD, PhD, FRCPC	Dr. Mirsattari has nothing to disclose.
Mark Agostini, MD	Dr. Agostini has nothing to disclose.
Kuljeet S. Anand, MD	No disclosure on file
Ann-Marie Beaudoin	No disclosure on file
Charlie Conway	Charlie Conway has received personal compensation for serving as an employee of Biohaven Pharmaceuticals Inc. Charlie Conway has received stock or an ownership interest from Biohaven Pharmaceuticals.
Alexander Sandweiss, MD, PhD	Dr. Sandweiss has nothing to disclose.
Nasser Y. Alohaly, MBBS	No disclosure on file
Tetsuya Takahashi, PhD	No disclosure on file
David C. Diosy, MD	Dr. Diosy has nothing to disclose.
Rebecca E. Matthews, MD	Dr. Matthews has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Penry Epilepsy Programs.
Carolina Barnett Tapia, MD	Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD pharma. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Barnett Tapia has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. The institution of Dr. Barnett Tapia has received research support from Department of defense. The institution of Dr. Barnett Tapia has received research support from Muscular dystrophy canada. The institution of Dr. Barnett Tapia has received research support from MgNet. The institution of Dr. Barnett Tapia has received research support from NIH. The institution of Dr. Barnett Tapia has received research support from Cartesian. The institution of Dr. Barnett Tapia has received research support from Alexion. Dr. Barnett Tapia has received intellectual property interests from a discovery or technology relating to health care.
Bruno Colombo	Bruno Colombo has nothing to disclose.
Susan M. Bowyer, PhD	Dr. Bowyer has nothing to disclose.
Robert A. Bermel, MD, FAAN	Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Giulia Pierangeli, MD	No disclosure on file
Lawrence Korngut, MD	Dr. Korngut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Korngut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Korngut has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Yoshie Umemura, MD, FAAN	Dr. Umemura has received personal compensation for serving as an employee of Barrow Neurological Institute. Dr. Umemura has received personal compensation for serving as an employee of University of Michigan. Dr. Umemura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Qessential. Dr. Umemura has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Servier. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with Curio Science LLC. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with OncLive. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with MJH Life Sciences.
Sabina Cevoli	Sabina Cevoli has nothing to disclose.
Carlen A. Yuen, MD	Dr. Yuen has nothing to disclose.
Annie Dionne, MD	Dr. Dionne has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Dionne has received research support from Sanofi.
Ornella M. Dubaz, MD	No disclosure on file
Ricardo F. Allegri, MD, PhD, FAAN	Dr. Allegri has nothing to disclose.
Gianna Carla Riccitelli	No disclosure on file
Lana Chahine, MD, FAAN	Dr. Chahine has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gray Matters Technology. The institution of Dr. Chahine has received research support from UPMC. The institution of Dr. Chahine has received research support from MJFF. The institution of Dr. Chahine has received research support from Denali/Biogen. Dr. Chahine has received publishing royalties from a publication relating to health care.
Leonardo Brito De Almeida, MD	Dr. Brito De Almeida has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Brito De Almeida has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boston Scientific.
Muhammad O. Salim Khan, DO	Dr. Salim Khan has nothing to disclose.
Christine M. Doherty	Ms. Doherty has received research support from American Academy of Neurology.
Oliver Nguyen	Oliver Nguyen has nothing to disclose.
Gary L. Pattee, MD	The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA pharmaceuticals. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA pharmaceiticals. The institution of Dr. Pattee has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for General Dynamics US military. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka pharmaceuticals.
James P. Wymer, MD, PhD, FAAN	No disclosure on file
Sumit Parikh, MD	Dr. Parikh has received personal compensation in the range of $0-$499 for serving as a Consultant for Epirium. The institution of Dr. Parikh has received research support from CHAMP. The institution of Dr. Parikh has received research support from Mitochondrial Medicine Society. The institution of Dr. Parikh has received research support from Minovia. The institution of Dr. Parikh has received research support from Acadia. The institution of Dr. Parikh has received research support from Stealth. Dr. Parikh has received publishing royalties from a publication relating to health care.
Connie C. Marras, MD	Dr. Marras has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. The institution of Dr. Marras has received research support from Theravance Inc. The institution of Dr. Marras has received research support from Centogene.
Ismael Calandri, MD	Dr. Calandri has nothing to disclose.
Isabel Santana	No disclosure on file
Gamaleldin M. Osman, MD	Dr. Osman has nothing to disclose.
Angela L. Genge, MD	Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AL-S Pharma. Dr. Genge has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Genge has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Quralis. Dr. Genge has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Genge has received personal compensation in the range of $0-$499 for serving as a Consultant for WAVE. Dr. Genge has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for eikonizo. Dr. Genge has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for rapa.
Wei Xu	No disclosure on file
Pyay San	No disclosure on file
Asad Ikram, MD, MBBS	Dr. Ikram has nothing to disclose.
Santiago Ortega Gutierrez, MD	Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for stryker. Dr. Ortega Gutierrez has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for medtronic. Dr. Ortega Gutierrez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. The institution of Dr. Ortega Gutierrez has received research support from Methinks. The institution of Dr. Ortega Gutierrez has received research support from NIH. The institution of Dr. Ortega Gutierrez has received research support from PCORI.
Joshua M. Cohen, MD	No disclosure on file
Samir Belagaje, MD, FAAN	Dr. Belagaje has nothing to disclose.
Sonia Batista, MD	Dr. Batista has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Novartis, Roche, Sanofi Genzyme, Merck. Dr. Batista has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Novartis, Roche, Sanofi Genzyme, Merck.
QIANG DONG, PhD	No disclosure on file
J. Kent Werner, Jr., MD, PhD	Dr. Werner has received personal compensation for serving as an employee of Cogentis Therapeutics. Dr. Werner has stock in Cogentis Therapeutics. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received intellectual property interests from a discovery or technology relating to health care. Dr. Werner has received personal compensation in the range of $100,000-$499,999 for serving as a Neurologist with United States Navy. Dr. Werner has received personal compensation in the range of $50,000-$99,999 for serving as a CEO / CoFounder with Cogentis Therapeutics.
Rena Sukhdeo Singh, MD	No disclosure on file
Sarah Madani, MD	No disclosure on file
Justin Abbatemarco, MD	Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech . Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics, Inc.. Dr. Abbatemarco has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. The institution of Dr. Abbatemarco has received research support from Amgen.
Fabrizio Vernieri	No disclosure on file
Rutvij J. Shah, MD, MBBS	No disclosure on file
Sajid Suriya, MD	Dr. Suriya has nothing to disclose.
Sharlet Anderson, PhD	Dr. Anderson has nothing to disclose.
Linda Wietecha, RN, MS	Ms. Wietecha has received personal compensation for serving as an employee of Eli Lilly and Company. Ms. Wietecha has received stock or an ownership interest from Eli Lilly and Company.
Bhavna Kaul, MD	No disclosure on file
Carmen Gasca-Salas, MD	Dr. Gasca-Salas has received personal compensation in the range of $500-$4,999 for serving as a Speaker (lecturing) with Esteve and Exeltis.
Myassar Zarif	Myassar Zarif has nothing to disclose.
Angelia Kirkpatrick	Angelia Kirkpatrick has nothing to disclose.
Diana Sima	Diana Sima has received personal compensation for serving as an employee of icometrix.
Ralph H. Benedict, PhD	Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Bappaditya Ray, MD	Dr. Ray has nothing to disclose.
Prakash Ambady, MD	No disclosure on file
Chandrashekhar Agrawal, MD	No disclosure on file
Marisara Dieppa, MD	Dr. Dieppa has nothing to disclose.
Si Baek Lee	Si Baek Lee, 1512 has nothing to disclose.
Eldbjorg Hustad, MD, PhD	No disclosure on file
Jennifer Adrissi, MD	Dr. Adrissi has nothing to disclose.
Trevor Jairam, MD	Trevor Jairam has nothing to disclose.
Irina Podkorytova	Irina Podkorytova has nothing to disclose.
David R. Colelli, MSc	Mr. Colelli has nothing to disclose.
Albert Lamontagne, MD	No disclosure on file
Gilbert J. L'Italien	Gilbert J. L'Italien has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gilbert J. L'Italien has stock in biohaven pharmaceuticals.
Amanda Brown, PhD	No disclosure on file
Karlo Toljan, MD	Dr. Toljan has nothing to disclose.
Seon Kyung Nam, MD	Dr. Nam has nothing to disclose.
Ronghua Yang, PhD	No disclosure on file
Scott Husak	Scott Husak has nothing to disclose.
Carl DeMoor	Carl DeMoor has received personal compensation for serving as an employee of Biogen. Carl DeMoor has received stock or an ownership interest from Biogen. An immediate family member of Carl DeMoor has received personal compensation in the range of $100,000-$499,999 for serving as a Program Director with NIH.
Sindhu Reddy Pisati, MD, MBBS	Dr. Pisati has nothing to disclose.
Karissa Johnston	Karissa Johnston has nothing to disclose.
Samantha R. Cencer, DO	Dr. Cencer has nothing to disclose.
Pashtun-Poh Shahim, MD, PhD	Pashtun-Poh Shahim has nothing to disclose.
Ali Al Jarrah	Mr. Al Jarrah has nothing to disclose.
Thiago A. Rodrigues, MD	Dr. Rodrigues has nothing to disclose.
Lynda Nwabuobi, MD	Dr. Nwabuobi has received personal compensation in the range of $0-$499 for serving as a Consultant for KX Advisors. Dr. Nwabuobi has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Healthgrades. Dr. Nwabuobi has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Consultant 360.
Denis Vezina, PhD	No disclosure on file
Nandakumar Nagaraja, MD	The institution of Dr. Nagaraja has received research support from 1 Florida Alzheimer's Disease Research Center. Dr. Nagaraja has received personal compensation in the range of $500-$4,999 for serving as a stroke outcome adjudicator for WHI study with Fred Hutchinson Cancer Research Center.
Neil E. Schwartz, MD, PhD	Dr. Schwartz has nothing to disclose.
Raisa Saron W. Murari, MD	No disclosure on file
Kelly L. Block, DO	Dr. Block has nothing to disclose.
Alina Shub, PA	The institution of Ms. Shub has received research support from Abbott and Boston Scientific .
Rosario Vasta, MD	Dr. Vasta has nothing to disclose.
Lukas Sveikata	No disclosure on file
Youmna Jalkh	Ms. Jalkh has nothing to disclose.
Arthur Ramalho Monfredinho, MD	Dr. Ramalho Monfredinho has nothing to disclose.
Moein Amin, MD	Dr. Amin has nothing to disclose.
Akashleena Mallick, MD, MBBS	Dr. Mallick has nothing to disclose.
Luis Fernandez	No disclosure on file
Elyse Stock	Elyse Stock has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. An immediate family member of Elyse Stock has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Biohaven Pharmaceuticals. An immediate family member of Elyse Stock has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Flagship Pioneering Management. An immediate family member of Elyse Stock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol-Myers Squibb. An immediate family member of Elyse Stock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Optinose. An immediate family member of Elyse Stock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abpro. An immediate family member of Elyse Stock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adagio. Elyse Stock has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Biohaven Pharmaceuticals. Elyse Stock has received stock or an ownership interest from Biohaven Pharmaceuticals. An immediate family member of Elyse Stock has received stock or an ownership interest from BIohaven Pharmaceuticals.
Richard McLachlan, MD	No disclosure on file
Elias S. Sotirchos, MD	Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Sotirchos has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Sotirchos has received research support from National Institutes of Health. The institution of Dr. Sotirchos has received research support from National Multiple Sclerosis Society. The institution of Dr. Sotirchos has received research support from Sumaira Foundation. The institution of Dr. Sotirchos has received research support from Genentech. The institution of Dr. Sotirchos has received research support from UCB. The institution of Dr. Sotirchos has received research support from Astoria Biologica. The institution of Dr. Sotirchos has received research support from Ad Scientiam. The institution of Dr. Sotirchos has received research support from Alexion. The institution of Dr. Sotirchos has received research support from Corevitas. Dr. Sotirchos has received personal compensation in the range of $500-$4,999 for serving as a Ad Hoc Reviewer with National Institutes of Health.
Orla Hardiman, MD, DSc, FRCPI, MRIA, FAAN	Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Dale J. Lange, MD, FAAN	No disclosure on file
Sabrina Paganoni, MD, PhD	Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jannsen. Dr. Paganoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arrowhead. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Sola. Dr. Paganoni has received personal compensation in the range of $0-$499 for serving as a Consultant for Frequency Therapeutics. The institution of Dr. Paganoni has received research support from Amylyx. The institution of Dr. Paganoni has received research support from Revalesio. The institution of Dr. Paganoni has received research support from Alector. The institution of Dr. Paganoni has received research support from UCB. The institution of Dr. Paganoni has received research support from Biohaven. The institution of Dr. Paganoni has received research support from Clene. The institution of Dr. Paganoni has received research support from Prilenia. The institution of Dr. Paganoni has received research support from Seelos. The institution of Dr. Paganoni has received research support from Calico. The institution of Dr. Paganoni has received research support from Denali. The institution of Dr. Paganoni has received research support from Anelixis. The institution of Dr. Paganoni has received research support from Cytokinetics.
Zaza Katsarava, MD	Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Zaza Katsarava, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
Ayaz M. Khawaja, MD	Dr. Khawaja has nothing to disclose.
Licia Grazzi, MD	Dr. Grazzi has received personal compensation in the range of $0-$499 for serving as a Consultant for EliLilly. Dr. Grazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan-abbvie.
Joel N. Phillips, DO, FAAN	Dr. Phillips has nothing to disclose.
Ana Margarida Novo, MD	No disclosure on file
Neil K. Shetty, MD	No disclosure on file
Marion Oliver, MD	Dr. Oliver has nothing to disclose.
Larry Junck, MD	Dr. Junck has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus Therapeutics. Dr. Junck has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier Pharmaceuticals, LLC. Dr. Junck has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Bowman & Brooke.
Jacob S. Elkins, MD	No disclosure on file
Marta Radaelli	Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme.
Adolfo Ramirez Zamora, MD	Dr. Ramirez Zamora has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel therapeutics. Dr. Ramirez Zamora has received personal compensation in the range of $0-$499 for serving as a Consultant for NeuroPacs. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota Inc. Dr. Ramirez Zamora has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maplight. Dr. Ramirez Zamora has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. The institution of Dr. Ramirez Zamora has received research support from Parkinsons Foundation.
Aman Deep, MD	Dr. Deep has nothing to disclose.
Domenico D'Amico	No disclosure on file
Evan Popoff	No disclosure on file
Angelique M. Manasseh, DO	No disclosure on file
Dania Qaryouti, MD	Dr. Qaryouti has nothing to disclose.
Taha Nisar, MD	Dr. Nisar has nothing to disclose.
Holland Detke	Holland Detke has received personal compensation for serving as an employee of Eli Lilly and Company. Holland Detke has received stock or an ownership interest from Eli Lilly and Company.
Stephen Aradi, MD	Dr. Aradi has nothing to disclose.
Bahareh Sianati, MD	No disclosure on file
Martin Berghoff, MD, FAAN	Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MerckSerono. Dr. Berghoff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb.
Maromi Nei, MD	No disclosure on file
Barbara Fossati, MD	No disclosure on file
James P. Valeriano, MD	Dr. Valeriano has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for ucb. Dr. Valeriano has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for neurilis.
Stephanie Grover, MSc, CCRP	No disclosure on file
Scott Grossman, MD	Dr. Grossman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acuta Pharmaceuticals.
Daniel Krashin, MD	Dr. Krashin has nothing to disclose.
Piotr Bzdyra, MD	No disclosure on file
Antje Tockhorn-Heidenreich	Antje Tockhorn-Heidenreich has received personal compensation for serving as an employee of Eli Lilly and Company. An immediate family member of Antje Tockhorn-Heidenreich has received personal compensation for serving as an employee of Evidera. Antje Tockhorn-Heidenreich has received stock or an ownership interest from Eli Lilly and Company . An immediate family member of Antje Tockhorn-Heidenreich has received stock or an ownership interest from PPD.
Svetlana Eckert, MD	Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Eckert has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics.
Alejandro Gonzalez Aquines, Sr.	Mr. Gonzalez Aquines has nothing to disclose.
Daniela L. Giardino, MD	No disclosure on file
W. M. Mulleners, MD	No disclosure on file
Akanksha Sharma, MD	Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Generation Care Hospice. Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curio Science. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Sharma has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Sharma has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDPI. Dr. Sharma has or had stock in Roon. The institution of Dr. Sharma has received research support from Chimerix. The institution of Dr. Sharma has received research support from Novocure. Dr. Sharma has a non-compensated relationship as a Advisory Board with Elevate Med that is relevant to AAN interests or activities.
Ethan Murphy	No disclosure on file
Russell Nichols	Russell Nichols has received personal compensation for serving as an employee of Eli Lilly and Company. Russell Nichols has received stock or an ownership interest from Eli Lilly and Company.
Francesca Macaluso	No disclosure on file
Shashvat Desai, MD	Dr. Desai has nothing to disclose.
Vito A. Ricigliano	Mr. Ricigliano has received personal compensation in the range of $500-$4,999 for serving as a Expert with M3 global research, Biogen and Atheneum Partners.
SHUN YAO, MD	Dr. YAO has nothing to disclose.
Kathryn Devlin	No disclosure on file
Hilda V. Gutierrez, MD	Ms. Gutierrez has nothing to disclose.
Badria Munir, MD	Dr. Munir has nothing to disclose.
Seyedamirhosein Motamedi, PhD	Mr. Motamedi has nothing to disclose.
Amina Coffey	No disclosure on file
Alan Little, MD	Dr. Little has received personal compensation for serving as an employee of Willis Knighton Health System. Dr. Little has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion .
Katherine Selwa, MD	No disclosure on file
Shane Bross	No disclosure on file
Dallah Yoo, MD, PhD	No disclosure on file
Ashley Nelson, DO	Dr. Nelson has nothing to disclose.
Ekhlas Assaedi, MD	Dr. Assaedi has nothing to disclose.
David Stock	David Stock has nothing to disclose.
Alaina Giacobbe, MD	Dr. Giacobbe has nothing to disclose.
Teri R. Thomsen, MD	Dr. Thomsen has nothing to disclose.
Terry D. Heiman-Patterson, MD	Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
E. Ann Yeh, MD, MA, FRCPC	Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to AAN interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to AAN interests or activities.
Tammie Benzinger	Tammie Benzinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tammie Benzinger has received personal compensation in the range of $0-$499 for serving as a Consultant for Sora Neuroscience. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Tammie Benzinger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol, Myers Squibb. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for PeerView. Tammie Benzinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. The institution of Tammie Benzinger has received research support from Siemens. The institution of Tammie Benzinger has received research support from Hyperfine. Tammie Benzinger has a non-compensated relationship as a Consultant with Siemens that is relevant to AAN interests or activities. Tammie Benzinger has a non-compensated relationship as a Consultant with Eisai that is relevant to AAN interests or activities.
Bichun Ouyang	Bichum Ouyang has nothing to disclose.
Shufang Wang	No disclosure on file
David Gritsch, MD, PhD	Dr. Gritsch has nothing to disclose.
Brittany M. Kasturiarachi, DO	Dr. Kasturiarachi has received personal compensation in the range of $500-$4,999 for serving as a Study Reviewer with EchoNous.
Stephen Apple	Stephen Apple has received personal compensation for serving as an employee of Mitsubishi Tanabe Pharma America, Inc.
Vincent Mysliwiec	No disclosure on file
Brent Jacobus II, MD	Dr. Jacobus has nothing to disclose.
Arthur Alcantara Lima, MD	Dr. Alcantara Lima has nothing to disclose.
Mark Girgis, DO	Dr. Girgis has nothing to disclose.
Joseph F. Imbs IV, DO	Dr. Imbs has nothing to disclose.
Patrick W. Kerns, MD, PhD	No disclosure on file
Steffen Paschen	The institution of Steffen Paschen has received research support from Deutsche Forschungsgemeinschaft. The institution of Steffen Paschen has received research support from Parkinsonfonds. The institution of Steffen Paschen has received research support from UCB .
Andrea Abousamra, DO	Dr. Abousamra has nothing to disclose.
Barbara A. Pickut, MD	Prof. Pickut has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin.
Danielle A. Bazer, DO	Dr. Bazer has received research support from Keep Punching.
Renxin Chu	Dr. Chu has nothing to disclose.
Christy Smith	No disclosure on file
Sean Levy	No disclosure on file
Shirley Liao	Shirley Liao has received personal compensation for serving as an employee of Biogen.
Maria Laura Blefari	No disclosure on file
Lauren M. Webb, MD	Dr. Webb has nothing to disclose.
Anastasia Skalnaya, MD	Dr. Skalnaya has nothing to disclose.
Mhd Omar Subei, MD	Dr. Subei has nothing to disclose.
Mary Clare McKenna, MB BCh BAO PhD	Dr. McKenna has nothing to disclose.
Lucas D. Peixoto, MD	Dr. Peixoto has nothing to disclose.
Ekta G. Shah, DO, MS	No disclosure on file
Deepaneeta Sarmah, M Pharm	Miss Sarmah has nothing to disclose.
Thiago D. Pinheiro, MD	Dr. Pinheiro has nothing to disclose.
Amreen Farooqui, MD	Dr. Farooqui has nothing to disclose.
Lisa Glukhovsky, PhD	No disclosure on file
Elizabeth Delaney, MD	No disclosure on file
Christopher P. Mackintosh	No disclosure on file
Nicholas Levitt	Nicholas Levitt has received personal compensation for serving as an employee of Biogen Inc..
Ryan Halter	No disclosure on file
Kevin Senanayake	No disclosure on file
Christina M. Boada, MD, MS	Dr. Boada has nothing to disclose.
Bernard Bendok, MD	No disclosure on file
Matheus N. Castro, MD	Dr. Castro has nothing to disclose.
Chang Brian H. Jung, MD	No disclosure on file
Laura Sander, MD	Dr. Sander has nothing to disclose.
Hemani Ticku, MD	Dr. Ticku has nothing to disclose.
Yarema Bezchlibnyk	Yarema Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Yarema Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PMT Inc. Yarema Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbott. Yarema Bezchlibnyk has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Boston Scientific. Yarema Bezchlibnyk has received research support from Medtronic.
Anuradha Singh, DO	Dr. Singh has nothing to disclose.
Pallab Bhattacharya, PhD	Dr. Bhattacharya has nothing to disclose.
Shubham Misra, PhD	Dr. Misra has nothing to disclose.
Alise K. Carlson, MD	Dr. Carlson has received research support from Biogen (fellowship grant 16696-P-FEL).
Jane Shaji, MD	No disclosure on file
Korhan Buyukturkoglu, PhD	Dr. Buyukturkoglu has nothing to disclose.
Hiral Shah, MD	Dr. Shah has nothing to disclose.
Abdullah Bin Zahid, MD	No disclosure on file
Pooneh Memar Ardestani, MD, PhD	Dr. Memar Ardestani has nothing to disclose.
Marcos Ravi C. Figueiredo, MD	No disclosure on file